Abstract
Recent changes in rules regarding waivers for buprenorphine prescribing and the FDA approval of several buprenorphine formulations were among topics discussed at IPS: The Mental Health Services Con...
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have